Kusmo recently completed a successful exhibition tour at several major national physician conferences, including the American College of Emergency Physicians (Las Vegas 2024), American College of Chest Physicians (Boston 2024), American Society of Anesthesiologists (Philadelphia 2024), American Heart Association (Chicago 2024), American College of Cardiology (Chicago 2025), and Heart Rhythm Society (San Diego 2025).
Dr. Walter Kusumoto remarked,
"I’m thrilled by the enthusiastic response we received for our flagship product, CaTHSTiX. We look forward to introducing new solutions to support physicians managing catheters across multiple hospital settings. I’m incredibly proud of our team’s dedication and hard work that made this tour possible."
Kusmo has received FDA confirmation that CaTHSTiX is classified as a Class I medical device. With this designation secured, we are moving forward with commercial development and initiating production of the first manufacturing batch.
“I’m thrilled to see CaTHSTiX achieve Class I designation from the FDA. This milestone reflects the tremendous effort and commitment of our entire team. As we move forward into commercial development, our focus remains on bringing real value to patients, physicians, and hospital systems.” — Dr. Kusumoto
Add a footnote if this applies to your business